Study of Moderate or Severe Tricuspid Valve Leakage Patient Characteristics, Heart Imaging, and Long-Term Outcomes

What this Trial Is About

This research focuses on patients with moderate or severe tricuspid regurgitation TR, a condition affecting the tricuspid valve of the heart. The study aims to better understand the characteristics, natural history, prognosis, and management of TR, which is often difficult to evaluate with echocardiography and currently lacks well-defined treatment guidelines. TR frequently remains undiagnosed until advanced stages of right heart failure, where surgical options carry higher risks. Participants with moderate or severe TR will be followed prospectively and retrospectively in a cohort study. The study does not involve experimental treatments but collects clinical and echocardiographic data to analyze how TR progresses and impacts patient outcomes. The focus is on the evaluation of TR through transthoracic echocardiography and other clinical assessments to monitor heart function and valve status over time. During the study, participants will undergo regular clinical evaluations including echocardiograms and survival monitoring for up to five years. Researchers will gather data on overall survival and other health measures to improve knowledge about TR progression and prognosis. There are no investigational drugs or interventions given, and participants usual medical care will continue alongside this observational follow-up.

Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation